###begin article-title 0
Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions
###end article-title 0
###begin p 1
Conceived and designed the experiments: TO. Performed the experiments: JH. Analyzed the data: PV MSD RR SJA TO. Contributed reagents/materials/analysis tools: PV MSD RR GMH WS JS. Wrote the paper: PV MSD GMH TO.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
S1PL is an aldehyde-lyase that irreversibly cleaves sphingosine 1-phosphate (S1P) in the terminal step of sphingolipid catabolism. Because S1P modulates a wide range of physiological processes, its concentration must be tightly regulated within both intracellular and extracellular environments.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 182 187 <span type="species:ncbi:10090">mouse</span>
In order to better understand the function of S1PL in this regulatory pathway, we assessed the in vivo effects of different levels of S1PL activity using knockout (KO) and humanized mouse models.
###end p 5
###begin title 6
Principal Findings
###end title 6
###begin p 7
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 428 431 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 453 456 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 702 705 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 461 466 <span type="species:ncbi:9606">human</span>
###xml 631 636 <span type="species:ncbi:10090">mouse</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
Our analysis showed that all S1PL-deficient genetic models in this study displayed lymphopenia, with sequestration of mature T cells in the thymus and lymph nodes. In addition to the lymphoid phenotypes, S1PL KO mice (S1PL-/-) also developed myeloid cell hyperplasia and significant lesions in the lung, heart, urinary tract, and bone, and had a markedly reduced life span. The humanized knock-in mice harboring one allele (S1PLH/-) or two alleles (S1PLH/H) of human S1PL expressed less than 10 and 20% of normal S1PL activity, respectively. This partial restoration of S1PL activity was sufficient to fully protect both humanized mouse lines from the lethal non-lymphoid lesions that developed in S1PL-/- mice, but failed to restore normal T-cell development and trafficking. Detailed analysis of T-cell compartments indicated that complete absence of S1PL affected both maturation/development and egress of mature T cells from the thymus, whereas low level S1PL activity affected T-cell egress more than differentiation.
###end p 7
###begin title 8
Significance
###end title 8
###begin p 9
These findings demonstrate that lymphocyte trafficking is particularly sensitive to variations in S1PL activity and suggest that there is a window in which partial inhibition of S1PL could produce therapeutic levels of immunosuppression without causing clinically significant S1P-related lesions in non-lymphoid target organs.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 78 81 78 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Chalfant1">[1]</xref>
###xml 82 85 82 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Saba1">[5]</xref>
###xml 250 253 250 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Chalfant1">[1]</xref>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Reiss1">[13]</xref>
###xml 427 430 427 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Hait1">[2]</xref>
###xml 432 435 432 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Pyne1">[4]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Saba2">[14]</xref>
###xml 701 704 701 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Chalfant1">[1]</xref>
###xml 706 709 706 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Hait1">[2]</xref>
###xml 711 714 711 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Pyne1">[4]</xref>
###xml 716 719 716 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Liao1">[9]</xref>
###xml 721 725 721 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Maceyka1">[10]</xref>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Oskouian1">[12]</xref>
###xml 733 737 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Saba2">[14]</xref>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Rosen1">[16]</xref>
Sphingosine 1-phosphate (S1P), a breakdown product of sphingolipid metabolism [1]-[5], is present in all mammalian cells and serves as second messenger in signal transduction pathways that regulate cell differentiation, proliferation, and apoptosis -[1]-[13]. S1P is also released into the extracellular milieu by a variety of cell types, making it one of the most abundant biologically active lysophospholipids in circulation [2], [4], [14]. Autocrine and paracrine interactions between S1P and a family of G protein-coupled receptors (S1P1-S1P5) have been implicated in a wide range of physiological activities, including cardiovascular development and disease, neuronal cell survival, and immunity [1], [2], [4], [9], [10], [12], [14]-[16].
###end p 11
###begin p 12
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Hait1">[2]</xref>
###xml 193 196 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Leclercq1">[3]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Maceyka1">[10]</xref>
###xml 276 279 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Pyne1">[4]</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Saba2">[14]</xref>
###xml 492 495 492 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Pyne1">[4]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Oskouian1">[12]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Saba2">[14]</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Ikeda1">[17]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-vanVeldhoven1">[18]</xref>
###xml 598 601 598 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Pyne1">[4]</xref>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Saba2">[14]</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Ito1">[19]</xref>
Systemic and local concentrations of S1P are regulated directly by three classes of enzymes within the sphingolipid pathway. Reversible synthesis of S1P is mediated by sphingosine kinases [2], [3], [10], which phosphorylate sphingosine to produce S1P, and by S1P phosphatases [4], [14], which remove the phosphate. Irreversible degradation of S1P is carried out by a single enzyme, Sphingosine 1-phosphate lyase (S1PL), which cleaves S1P into ethanolamine phosphate and a long chain aldehyde [4], [12]-[14], [17], [18]. S1PL is present in most mammalian cells except for platelets and erythrocytes [4], [14], [19], but its relative abundance varies by tissue and cell type.
###end p 12
###begin p 13
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Sillence1">[20]</xref>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Schmahl1">[21]</xref>
###xml 673 678 <span type="species:ncbi:9606">human</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
The diverse effects of S1P make it difficult to dissect its role in different aspects of mammalian physiology and to predict the in vivo consequences of deficiency in S1P degrading enzymes, including S1PL. Disrupted lipid metabolism due to mutations in the catabolic enzymes of the sphingolipid pathway can result in sphingolipid storage diseases, which are characterized by the cellular storage and accumulation of the sphingolipid substrates [20]. The specific pathologic phenotype associated with each sphingolipid storage disease depends on both the expression pattern of the affected catabolic enzyme and the metabolic burden of each particular cell type. Although no human disease has been associated with S1PL deficiency, loss of S1PL in mice leads to stunted growth and early mortality, with defects reported in the kidney, bone, vasculature and myeloid cell lineages [21].
###end p 13
###begin p 14
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Liao2">[22]</xref>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Pettus1">[23]</xref>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-McVerry1">[24]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Wei1">[26]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Cyster1">[15]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Rosen1">[16]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Schwab1">[27]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Shiow1">[29]</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Schwab2">[28]</xref>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Shiow1">[29]</xref>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Schwab1">[27]</xref>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Cinamon1">[30]</xref>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Pham1">[35]</xref>
###xml 1076 1080 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Gardell1">[36]</xref>
###xml 1081 1085 1081 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Zhang1">[40]</xref>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
In the immune system, changes in local S1P concentration and gradient can alter inflammatory cell responses [22], [23], affect the barrier function of endothelial cells [24]-[26], and modify lymphocyte migration patterns [15], [16], [27]-[29]. Hematopoietic cell-specific knockdown of S1PL in the bone-marrow using RNA interference increased S1P levels in lymphoid organs and lead to lymphopenia after transplantation of the bone marrow into immunodeficient mice [28]. The described effect of S1PL knockdown is similar to that observed after treatment with the S1P-analog FTY720[29]. S1P and FTY720 elicit their effects on the immune system through interaction with the S1P1 receptor, which inhibits lymphocyte egress from primary and secondary lymphoid organs and in turn reduces the number of recirculating lymphocytes in peripheral blood [27], [30]-[35]. One physiological outcome of this systemic redistribution of lymphocytes is potent immunosuppression, which offers new opportunities for developing immunoregulatory agents to treat autoimmune and inflammatory diseases [36]-[40]. The S1P1 receptor is currently a target of pharmaceutical development, and enzymes of the S1P metabolic pathway may provide additional intervention points for improved therapeutic applications.
###end p 14
###begin p 15
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
In this study, we determined the levels of S1PL enzyme activity in gene knockout and humanized mouse models of S1PL deficiency and compared the in vivo immunological and pathological effects associated with different levels of S1PL enzyme activity. Our findings show that effects on the immune system, typically characterized by lymphopenia and alterations in lymphoid tissues, were present in all mice with reduced or absent S1PL activity. These results indicate that the immune system is particularly sensitive to alterations in S1PL activity. In contrast, the storage disease phenotype in knockout mice that was characterized by alveolar proteinosis, cardiomyopathy, osteopetrosis and urothelial vacuolization in KO mice was prevented by restoration of even low level S1PL activity in humanized mice. In summary, our findings suggest that partial inhibition of S1PL activity can produce potentially therapeutic immunosuppression without causing S1P-related storage disease lesions in non-lymphoid target organs.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
###xml 43 47 <span type="species:ncbi:10090">mice</span>
S1PL is required for normal development in mice
###end title 17
###begin p 18
###xml 45 49 45 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Zambrowicz1">[41]</xref>
###xml 160 173 160 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g001">Fig. 1A and B</xref>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 410 413 410 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 425 428 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 557 560 557 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 633 640 633 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g001">Fig. 1C</xref>
###xml 706 709 706 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 836 839 834 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 873 876 869 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 913 915 909 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 926 929 922 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1121 1124 1117 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
###xml 1183 1188 <span type="species:ncbi:10090">mouse</span>
S1PL-null mice were derived from an OmniBank [41] embryonic stem cell clone (OST58278) carrying a gene trap mutation within the second intron of the S1PL gene (Fig. 1A and B) Heterozygous mice (S1PL+/-) were viable and fertile and were intercrossed to obtain homozygous progeny. Over 900 offspring were produced in an essentially normal (1:2:1) Mendelian distribution (26.3% wild type (Wt; S1PL+/+), 52.1% S1PL+/-, 21.6% S1PL-/-), suggesting that S1PL is not essential for embryonic development and neonatal viability. S1PL activity was undetectable in S1PL-/- mice, and was accompanied by elevated levels of S1P in both the spleen (Fig. 1C) and serum (40-fold increase in KO mice compared to Wt). The S1PL-/- mice were smaller than their Wt littermates and failed to thrive during the first weeks of life (bodyweight 15.5+/-0.7 g, S1PL+/+, n = 23 versus 10.3+/-0.4 g, S1PL-/-, n = 20, at 4 weeks of age, p = 3x10-7). All S1PL-/- mice in our study died by 15 weeks of age, having a median life span of 29 days (min. 22 days, max. 105 days, n = 55). The reduced viability and blood phenotype (described later) of this S1PL-/- gene-trap line was recapitulated in another S1PL knockout mouse line generated by homologous recombination in which exons 7-8 were replaced by a cre-lox selection cassette (data not shown).
###end p 18
###begin title 19
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Generation of S1PL mutant mice.
###end title 19
###begin p 20
###xml 449 479 446 476 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTAGCAGGCTTTCTTAACTCTGG-3&#8242;</named-content>
###xml 488 517 485 514 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTGGGAAGGTCCTGGTCATTACT-3&#8242;</named-content>
###xml 640 669 637 666 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATAAACCCTCTTGCAGTTGCATC-3&#8242;</named-content>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 1036 1040 <span type="species:ncbi:10090">mice</span>
(A) Gene trap mutation of the S1PL gene. The insertion occurred within intron 2 of the S1PL gene (NM_009163). LTR, viral long terminal repeat; SA, splice acceptor sequence; IRES, internal ribosome entry site; betaGeo, fusion of beta-galactosidase and neomycin phosphotransferase genes; pA, polyadenylation sequence; PGK, phosphoglycerate kinase-1 promoter; BTK-SD, Bruton's tyrosine kinase splice donor sequence. (B) Genotyping strategy. Primers F (5'-TGTAGCAGGCTTTCTTAACTCTGG-3') and R (5'-TTGGGAAGGTCCTGGTCATTACT-3') flank the genomic insertion site and amplify a product of 321 nucleotides representing the Wt allele. The LTRrev primer (5'-ATAAACCCTCTTGCAGTTGCATC-3'), complementary to the gene trapping vector, amplifies a 193 nucleotide mutant allele in conjunction with primer F. (C) S1PL activity and S1P concentration were measured in spleen samples of the indicated mice. Enzyme activity was normalized to the mean of the Wt values; 100% corresponds to 172,898+/-15,344 cpm/mg/hr. Data were pooled from 2 experiments using 4-8 mice of each genotype, and data are presented as mean+/-SEM. * Activity was below the sensitivity of detection.
###end p 20
###begin title 21
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
S1PL-/- mice are lymphopenic due to altered lymphocyte development and tissue egress
###end title 21
###begin p 22
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 242 255 242 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g002">Fig. 2A and B</xref>
###xml 331 334 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 629 632 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 731 738 731 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g002">Fig. 2A</xref>
###xml 759 762 759 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 891 894 891 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 937 940 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
Complete blood cell count (CBC) and flow cytometry (FACS) analysis of peripheral blood of 4 week old S1PL-/- mice revealed an almost complete absence of peripheral T cells as well as severely reduced numbers of B cells compared to Wt values (Fig. 2A and B). Despite the severe lymphopenia, the total white blood cell counts of S1PL-/- mice were within the normal range due to a significant increase in monocyte and neutrophil numbers. Likewise, red blood cell counts in the S1PL-/- mice were not significantly different than those of Wt littermates (Wt 8.2+/-0.38, Hom 7.4+/-0.37 p = 0.12). Analysis of lymphoid tissues from S1PL-/- mice demonstrated decreased size and cellularity when cell counts were normalized to body weight (Fig. 2A). The thymus of S1PL-/- animals showed the most pronounced lymphocyte depletion, harboring only approximately 10% the number of lymphocytes seen in S1PL+/+ mice. The total lymphocyte numbers in S1PL-/- lymph nodes and spleens were 57% and 43% of those observed in Wt littermates, respectively.
###end p 22
###begin title 23
KO of S1PL disrupts both development and recirculation of lymphocytes.
###end title 23
###begin p 24
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 329 330 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 340 341 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 346 348 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 352 353 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 364 367 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 367 370 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 375 378 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
(A and B) Hematopoietic cell profile of the indicated tissues from S1PL+/+ (black bars) and S1PL-/- (white bars) mice determined by CBC and FACS analysis. Data are presented as mean+/-SEM values obtained from 11-18 mice of each genotype pooled from two independent experiments giving similar results. Numbers above bars indicate P values, *P<2x10-4, **P<0.05, S1PL-/-vs. S1PL+/+. Lymph, lymphocytes; Mono, monocytes; Neutro, neutrophil granulocytes.
###end p 24
###begin p 25
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Schwab2">[28]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Graler1">[31]</xref>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Matloubian1">[34]</xref>
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Mandala1">[38]</xref>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Rosen2">[39]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Yagi1">[42]</xref>
###xml 380 386 380 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g002">Fig. 2</xref>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g003">3</xref>
###xml 413 416 413 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 676 683 676 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g002">Fig. 2B</xref>
###xml 800 803 800 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 845 848 845 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1105 1112 1105 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g003">Fig. 3A</xref>
###xml 1123 1126 1123 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1256 1263 1253 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g003">Fig. 3B</xref>
###xml 1302 1305 1299 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1509 1513 1506 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Schwab2">[28]</xref>
###xml 1515 1519 1512 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Mandala1">[38]</xref>
###xml 1521 1525 1518 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Rosen2">[39]</xref>
###xml 1527 1531 1524 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Yagi1">[42]</xref>
###xml 1533 1537 1530 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Gabor1">[43]</xref>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
The altered lymphocyte counts in S1PL-/- mice were similar to those reported following modulation of the S1P-S1P1 receptor axis [28], [31], [34], [38], [39], [42]. Therefore, we assessed the phenotypes of lymphocyte subpopulations residing in the immune tissues by using markers of cell differentiation and lymphocyte egress, such as CD69 and a series of cell adhesion molecules (Fig. 2 and 3). The thymus of S1PL-/- mice showed a severe depletion of CD4 and CD8 double positive (DP) thymocytes compared to controls, but we did not observe an increase in the CD4 and CD8 double negative (DN) cell population as would be expected from a block at the DN to DP transition stage (Fig. 2B). Instead, the proportion of mature CD4 and CD8 single positive (SP) cells was 5-fold higher in the age-matched S1PL-/- mice compared to Wt littermates. The S1PL-/- mature thymocytes had normal surface density of the TCR and the coupled CD3 molecule (data not shown), but completely lacked the expression of CD69, a marker of early medullary thymocytes, which constitute the majority of SP thymocytes in normal controls (Fig. 3A). The S1PL-/- SP thymocytes also showed relatively high expression of CD62L and beta7 integrin, but reduced levels of CD24 and CD44 molecules (Fig. 3B). These phenotypic changes in the S1PL-/- mature thymocyte population are consistent with a block in the migration of lymphocytes into the periphery and a concomitant accumulation of mature thymocytes in the thymus of the S1PL-deficient animals [28], [38], [39], [42], [43].
###end p 25
###begin title 26
Absence of S1PL leads to accumulation of mature medullary thymocytes.
###end title 26
###begin p 27
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 389 392 389 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 416 419 416 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 734 737 731 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 766 769 763 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 951 955 <span type="species:ncbi:10090">mice</span>
(A) Representative FACS histograms of expression of the CD69 and CD62L markers on S1PL+/+ (shaded histograms) and S1PL-/- (open histograms) CD4 and CD8 SP thymocytes. The fraction of electronically gated CD4 and CD8 SP thymocytes that exhibit the indicated phenotypes (demarcated by the solid vertical lines) are depicted in graphical form. Datapoints represent values from individual S1PL+/+ (grey circles) and S1PL-/- (white circles) mice. Vertical dashed lines on the CD62L histograms indicate the cut-off values for positive staining obtained with isotype-matched control antibodies, which overlapped with the solid lines on the CD69 histograms. (B) Representative FACS histograms of CD24, CD44, and beta7 integrin density on S1PL+/+ (shaded histograms) and S1PL-/- (open histograms) SP thymocytes, gated for single expression of either the CD4 or CD8 markers. Vertical dashed lines represent cut-off values as in (A). Samples from two additional mice of each genotype gave similar results.
###end p 27
###begin p 28
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 187 190 187 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 314 321 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g004">Fig. 4A</xref>
###xml 387 390 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 535 555 535 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g004">Fig. 4B, upper panel</xref>
###xml 818 821 818 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 943 963 943 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g004">Fig. 4B, lower panel</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
Histopathological analysis of thymus from S1PL-/- mice revealed severe cortical lymphoid depletion with concurrent medullary hypercellularity. The thymic cortex of normal age-matched S1PL+/+ mice was densely packed with thymic lymphocytes and thus appeared to be broader and more cellular than the thymic medulla (Fig. 4A). This arrangement was essentially reversed in the thymus of S1PL-/- mice, where the hypoplastic thymic cortex appeared as a thin pale hypocellular zone due to the severe, diffuse depletion of thymic lymphocytes (Fig. 4B, upper panel); the few remaining cells in the thymic cortex consisted of vacuolated stromal/epithelial cells mixed with smaller numbers of granulocytes, macrophages, lymphocytes, and apoptotic cells. In contrast, the markedly expanded and hypercellular thymic medulla of S1PL-/- mice contained numerous mature lymphocytes as well as vacuolated stromal/epithelial cells, macrophages, and histiocytes (Fig. 4B, lower panel).
###end p 28
###begin title 29
Histopathology of Thymus.
###end title 29
###begin p 30
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 510 513 510 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 656 659 656 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 825 828 825 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
(A) S1PL+/+ thymus: A broad thymic cortex is densely packed with thymic lymphocytes (lower panel) (B) S1PL-/- thymus: The hypoplastic cortex is very thin and hypocellular due to severe cortical lymphoid depletion and apoptosis. At higher magnification (lower panel) the remaining cells in the thymic cortex include vacuolated stromal/epithelial cells and smaller numbers of granulocytes, macrophages, lymphocytes, and apoptotic cells. In contrast, the markedly expanded and hypercellular thymic medulla of S1PL-/- mice contains numerous mature lymphocytes as well as vacuolated stromal/epithelial cells, macrophages, and histiocytes (lower panel). (C) S1PLH/H thymus: The cortex contains minimally decreased numbers of lymphocytes while there is a minimal expansion of the medulla by increased numbers of lymphocytes (D) S1PLH/- thymus: Thinning of the thymic cortex is accompanied by mild expansion of the medulla due primarily to increased numbers of lymphocytes (lower panel). H&E stain.
###end p 30
###begin p 31
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 407 414 407 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g002">Fig. 2B</xref>
###xml 446 449 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 557 564 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g005">Fig. 5A</xref>
###xml 575 578 575 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 684 704 684 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g005">Fig. 5B, upper panel</xref>
###xml 856 876 856 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g005">Fig. 5B, upper panel</xref>
###xml 1097 1118 1097 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g005">Fig. 5B, middle panel</xref>
###xml 1442 1462 1442 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g005">Fig. 5B, lower panel</xref>
###xml 1593 1600 1593 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g006">Fig. 6A</xref>
###xml 1623 1626 1623 1626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1633 1640 1633 1640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g006">Fig. 6B</xref>
###xml 1723 1726 1723 1726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1735 1755 1735 1755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g006">Fig. 6B, lower panel</xref>
###xml 2070 2073 2070 2073 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
###xml 1627 1631 <span type="species:ncbi:10090">mice</span>
###xml 2074 2078 <span type="species:ncbi:10090">mice</span>
FACS analysis of cell suspensions from the secondary lymphoid organs revealed that loss of S1PL had more consistent effects on T-cell content than B-cell content of these tissues. S1PL-/- mice registered only 25% of normal T-lymphocyte counts in the lymph nodes and spleen. Although the B-cell content was reduced to 41% of the Wt level in the spleen, it was not significantly different in the lymph nodes (Fig. 2B). Histological analysis of S1PL-/- lymph nodes and intestinal mucosa showed that cell types and distributions differed from Wt mouse tissues (Fig. 5A). The S1PL-/- lymph nodes contained smaller B cell follicles and reduced numbers of lymphocytes in paracortical zones (Fig. 5B, upper panel). In mesenteric lymph nodes, lymphoid follicles appeared as small semicircular caps overlying expanded but relatively hypocellular paracortical zones (Fig. 5B, upper panel). The paracortex contained reduced numbers of lymphocytes, but markedly increased numbers of granulocytes and macrophages (some vacuolated and containing karyorrhectic debris), mixed with stromal cells and plasma cells (Fig. 5B, middle panel). The paracortex also showed a mild increase in collagenous stroma. The reduced numbers of lymphocytes and increased numbers of granulocytes in the paracortical areas of the mesenteric lymph nodes were mirrored by depletion of lymphocytes and increased numbers of granulocytes in the lamina propria of the small intestine (Fig. 5B, lower panel). In the spleen, the normal arrangement of periarteriolar lymphoid sheaths (PALS) and lymphoid follicles in the white pulp of Wt (Fig. 6A) was disrupted in S1PL-/- mice (Fig. 6B). The most notable finding was severe depletion of T cells in the PALS in the S1PL-/- spleen (Fig. 6B, lower panel). In contrast, B cell areas were relatively unaffected, with remaining lymphoid follicles and some germinal centers appearing more prominent due to the depletion of PALS. Other findings in the spleen included occasional clusters of plasma cells in the PALS and increased erythroid hematopoiesis in red pulp of S1PL-/- mice.
###end p 31
###begin title 32
Histopathology of mesenteric lymph nodes and intestinal lamina propria.
###end title 32
###begin p 33
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 469 472 469 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 623 626 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 760 763 760 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 863 866 863 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1032 1035 1032 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 1109 1112 1109 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
(A) S1PL+/+ lymph node: Paracortical zones are filled primarily with lymphocytes (B) S1PL-/- lymph node: Small B cell lymphoid follicles appear as small semicircular caps overlying an expanded but relatively hypocellular paracortical zones. At higher magnification (lower panel), the paracortex contains markedly increased numbers of granulocytes and macrophages (some vacuolated and containing karyorrhectic debris), mixed with stromal cells and plasma cells. (C) S1PLH/H lymph node: There is marked expansion of paracortical zones. At higher expansion, this expansion is due primarily to sequestered lymphocytes. (D) S1PLH/- lymph node: Similarly, the marked expansion of paracortical zones is due primarily to sequestered lymphocytes (lower panel). (E) S1PL+/+ lamina propria: Lymphocytes and plasma cells predominate in the lamina propria of Wt mice. (F) S1PL-/- lamina propria: There is a marked depletion of lymphocytes and plasma cells and increased numbers of granulocytes (arrows) in the intestinal lamina propria. (G) S1PLH/H lamina propria: Essentially normal cell populations are present. (H) S1PLH/- lamina propria: Essentially normal cell populations are present. H&E stain.
###end p 33
###begin title 34
Histopathology of Spleen.
###end title 34
###begin p 35
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 116 119 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 450 453 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 589 592 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
(A) S1PL+/+ spleen: Densely packed lymphocytes comprise the thick periarteriolar sheaths (PALS) in Wt mice. (B) S1PL-/- spleen: There is severe depletion of T cells in the PALS. The lymphocytes in the PALS have been replaced by small numbers of macrophages, granulocytes, and plasma cells. B cell areas are still evident, with remaining lymphoid follicles and some germinal centers appearing more prominent due to lymphoid depletion of PALS. (C) S1PLH/H spleen: The splenic white pulp contains essentially normal numbers and distributions of lymphocytes in the PALS and follicles. (D) S1PLH/- spleen: Again, the splenic white pulp contains essentially normal numbers and distributions of lymphocytes in the PALS and follicles. H&E stain.
###end p 35
###begin p 36
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 181 187 181 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g007">Fig. 7</xref>
###xml 332 335 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 435 441 435 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g007">Fig. 7</xref>
###xml 541 544 541 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
In the bone marrow, FACS analysis showed a lower ratio of mononuclear cells to granulocytes in S1PL-/- compared to S1PL+/+ mice as defined by the distinguishing scatter parameters (Fig. 7) and expression of the cell surface marker GR-1 (data not shown). In addition, the fraction of pre-B cells was significantly reduced in the S1PL-/- bone marrow, while the pro-B cell and mature B-cell subsets were present at their usual frequency (Fig. 7). Histopathological examination also showed increased granulocytopoiesis in the bone marrow of S1PL-/- mice (data nor shown).
###end p 36
###begin title 37
KO of S1PL disrupts hematopoietic cell development in the bone marrow.
###end title 37
###begin p 38
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
Representative FACS plots of bone marrow cells from the indicated mice, showing the scatter distribution of CD45 positive leukocytes and the alpha-B220/CD43 antibody staining patterns of the mononuclear cell fractions. Frequencies of events representing granulocytes, mononuclear cells and the B cell maturation stages are listed close to the respective gates. Dashed rectangles indicate the cut-off values for positive staining obtained with isotype-matched control antibodies. Samples from two additional mice of each genotype gave similar results.
###end p 38
###begin p 39
###xml 147 150 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
In summary, comparative assessment of the peripheral blood and primary and secondary lymphoid tissues indicated that the severe lymphopenia in S1PL-/- mice was due to alterations in the development and recirculation of lymphocytes, with the greatest impact on T-cell differentiation and egress.
###end p 39
###begin title 40
Effects of complete S1PL deficiency on non-lymphoid tissues
###end title 40
###begin p 41
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 221 228 221 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g008">Fig. 8B</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Histopathology of lungs from S1PL-/- mice revealed that virtually all pulmonary alveoli contained variable amounts of variably sized irregularly shaped polygonal flakes and clumps of smooth homogenous (hyaline) material (Fig. 8B). This proteinaceous material was generally free in the lumen but in many locations formed a thin layer lining the surface of alveolar septa. Associated with this alveolar exudate were markedly increased numbers of alveolar macrophages that were often distended by an abundant foamy and microvacuolated cytoplasm. Diffusely, alveolar septa were also mildly thickened due to cellular hypertrophy and collagen deposition.
###end p 41
###begin title 42
Histopathology of Lung.
###end title 42
###begin p 43
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
(A) S1PL+/+ lung: Alveolar spaces are generally clear and septa are thin in Wt mice (B) S1PL-/- lung: Alveoli contain variably sized irregularly shaped polygonal flakes and clumps of smooth homogenous (hyaline) material accompanied by increased numbers of alveolar macrophages. Alveolar septa are mildly thickened due to cellular hypertrophy and collagen deposition. H&E stain.
###end p 43
###begin p 44
###xml 134 137 134 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 183 203 183 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g009">Fig. 9, upper panels</xref>
###xml 330 350 330 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g009">Fig. 9, lower panels</xref>
###xml 460 479 460 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g009">Fig. 9 upper panels</xref>
###xml 519 522 519 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 644 664 644 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g009">Fig. 9, lower panels</xref>
###xml 702 705 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
Histological analysis of bone revealed an increase in the volume and extent of trabecular bone in the sternebra and long bones of S1PL-/- mutants. In comparison the bones of Wt mice (Fig. 9, upper panels) bony trabeculae extended throughout the marrow space in sternebrae and farther than normal into the diaphysis in long bones (Fig. 9, lower panels). In contrast to normal osteoclasts, which are usually tightly adherent and flattened against bone surfaces (Fig. 9 upper panels), the more numerous osteoclasts of S1PL-/- mice were distended by an abundant pale and granular eosinophilic cytoplasm that displaced cell nuclei to the periphery (Fig. 9, lower panels). Generally, these large rounded S1PL-/- osteoblasts had minimal direct contact with bone surfaces. They were present in increased numbers around mature trabecular bone in all areas, but they were particularly large and numerous in epiphyseal and diaphyseal regions distant from the physeal growth plate.
###end p 44
###begin title 45
Histopathology of Bone.
###end title 45
###begin p 46
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 392 395 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 550 553 550 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 749 752 749 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 894 897 894 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
S1PL+/+ Bone (A, B, and C): In Wt mice, the majority of the marrow cavity is filled with hematopoietic elements. Widely spaced trabeculae in long bones (A) and sternum (B) extend a relatively short distance from the physeal growth plate. At higher magnification (C), normal osteoclasts appear as multinucleated cells that are usually tightly adherent and flattened against bone surfaces. S1PL-/- Bone (D, E, and F): In marked contrast, there is a diffuse increase in the volume and extent of trabecular bone in the long bones (D) and sternum (E) S1PL-/- mice. The bony trabeculae extend throughout the marrow farther than normal into the diaphysis of long bones (D) and sternum (E). At higher magnification (F), the more numerous osteoclasts of S1PL-/- mice are distended by abundant pale and granular eosinophilic cytoplasm that displaces cell nuclei to the periphery. These large rounded S1PL-/- osteoblasts (arrows) have reduced direct contact with bone surfaces. H&E stain.
###end p 46
###begin p 47
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 228 236 228 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g010">Fig. 10B</xref>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Histopathologic lesions in the hearts of S1PL-/- mice were characterized by patchy to diffuse expansion of the interstitium by numerous variably-sized vacuoles and vacuolated mesenchymal cells that separated the cardiomyocytes (Fig. 10B). Scattered cardiomyocytes contained focal cytoplasmic lesions that ranged from indistinct foamy inclusions to sharply demarcated clear vacuoles and some cardiomyocytes had enlarged vesicular nuclei.
###end p 47
###begin title 48
Histopathology in other tissues.
###end title 48
###begin p 49
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 447 450 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 722 725 722 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 897 900 897 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 726 731 <span type="species:ncbi:10090">mouse</span>
###xml 901 906 <span type="species:ncbi:10090">mouse</span>
(A) S1PL+/+ heart: There is minimal interstitial tissue in Wt myocardium. (B) S1PL-/- heart: There is a patchy to diffuse expansion of the interstitium by numerous variably-sized vacuoles and vacuolated mesenchymal cells that separate the cardiomyocytes. Scattered cardiomyocytes contain indistinct foamy inclusions and sharply demarcated clear vacuoles. (C) S1PL+/+ urinary bladder: Normal urothelium lines the urinary bladder in Wt mice (D) S1PL-/- urinary bladder: There is widespread ballooning vacuolization, degeneration, and apoptosis of urothelial cell. Lesions are more severe in the superficial umbrella cell layer, where degenerating cells are interspersed among vacuolated urothelial cells. (E) Bone, aged S1PLH/- mouse: Small numbers of distended osteoclasts are present multifocally at the growth plate only. No increase in trabecular bone was evident. (F) Urinary bladder, aged S1PLH/- mouse: Rare vacuolated urothelial cells were present in the superficial mucosa. H&E stain.
###end p 49
###begin p 50
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g010">Fig. 10D</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
S1PL-/- mice also developed lesions affecting the urothelium lining the renal pelvis, ureters, and urinary bladder. These urothelial lesions were characterized by widespread ballooning vacuolization, degeneration, and apoptosis of urothelial cells (Fig. 10D). The most severe lesions were present in the superficial umbrella cell layer of urinary bladder urothelium, where small numbers of degenerating cells were interspersed among urothelial cells distended by large vacuoles that were either empty or partially filled with pale eosinophilic granular material.
###end p 50
###begin title 51
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Humanized knock-in mice are lymphopenic but do not develop non-lymphoid pathologies
###end title 51
###begin p 52
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 334 341 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g011">Fig. 11</xref>
###xml 371 374 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 507 515 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g011">Fig. 11D</xref>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 734 737 734 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 819 822 819 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 948 956 948 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g012">Fig. 12A</xref>
###xml 1084 1087 1084 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 1220 1228 1220 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g012">Fig. 12B</xref>
###xml 1410 1413 1410 1413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 1503 1511 1503 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g012">Fig. 12A</xref>
###xml 1554 1562 1554 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g012">Fig. 12B</xref>
###xml 1591 1594 1591 1594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 173 178 <span type="species:ncbi:9606">human</span>
###xml 208 213 <span type="species:ncbi:9606">human</span>
###xml 244 249 <span type="species:ncbi:10090">mouse</span>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
###xml 1414 1418 <span type="species:ncbi:10090">mice</span>
###xml 1595 1599 <span type="species:ncbi:10090">mice</span>
In order to obtain a mouse model for testing in vivo effects of S1PL-selective compounds and to rescue the defects observed in S1PL-/- mice we generated mice that express a human transgene. For this purpose, human S1PL cDNA was inserted at the mouse S1PL locus by homologous recombination, replacing the first exon of the mouse gene (Fig. 11). The resulting knock-in S1PLH/H mice exhibited S1PL activity at approximately 17% of normal Wt levels, which correlated with increased levels of S1P in the spleen (Fig. 11D) and serum (4-fold increase in humanized mice compared to Wt). The limited S1PL activity in the humanized S1PLH/H mice alleviated the pathological findings observed in the lungs, heart, bone, and urinary tracts of S1PL-/- mice, but did not rescue completely the immunological phenotypes. Transgenic S1PLH/H mice were viable and fertile, but registered significantly reduced peripheral lymphocyte numbers compared to Wt littermates (Fig. 12A). RBC numbers in the humanized mice were indistinguishable from Wt (Wt 10.0+/-0.16, S1PLH/H 10.0+/-0.19). T-cell counts in S1PLH/H mice were decreased substantially (by about 60%) in the peripheral blood and thymus, although not in the secondary lymphoid organs (Fig. 12B). Similarly, reduced B-cell numbers (by about 40%) were observed only in the peripheral blood, while monocyte and granulocyte counts were normal. FACS analysis of the thymus of S1PLH/H mice showed the characteristic increase in the proportion of single positive thymocytes (Fig. 12A) with markers of recent thymic emigrants (Fig. 12B) also being observed in S1PL-/- mice.
###end p 52
###begin title 53
Generation of humanized S1PL allele.
###end title 53
###begin p 54
###xml 281 284 281 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neo</italic>
###xml 330 342 330 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 351 368 351 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">metallothionein 2</italic>
###xml 810 817 810 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g001">Fig. 1C</xref>
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 330 342 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 650 655 <span type="species:ncbi:9606">human</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
(A) Schematic representation of the S1PL allele. Entire genomic locus spanning 15 exons indicated at the top. To create the humanized line, the coding portion of mouse exon 2 (first coding exon) was deleted and replaced with a full length human S1PL cDNA along with a LoxP-flanked Neo marker and a minigene to allow splicing. Hs, Homo sapiens; MT II, metallothionein 2 gene; Neo, neomycin resistance gene. (B) Genotyping strategy. Three correctly targeted clones (1D12, 1F2, 1G10) were identified by Southern blot analysis using 5' external and 3' internal probes. Lex-1, non-targeted, control ES cell DNA. (C) Expression analysis. Expression of the human S1PL gene was detected by RT-PCR. (D) S1PL activity and S1P concentration were measured in spleen samples of the indicated mice. Data are presented as in Fig. 1C.
###end p 54
###begin title 55
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human S1PL knock-in results in partial rescue of KO hematopoietic cell profile.
###end title 55
###begin p 56
###xml 293 306 293 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g002">Fig. 2A and B</xref>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 321 324 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 321 328 321 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>H/H</sup> vs.</italic>
###xml 333 336 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 552 558 552 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g007">Fig. 7</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
(A) Blood cell counts were obtained from 62-75 mice of each genotype pooled from seven independent experiments giving similar results. Total thymocyte counts and fractions of SP and DN cells were determined from 3 and 15 mice of each genotype, respectively. Data are presented as described in Fig. 2A and B; *P<0.02, S1PLH/H vs. S1PL+/+. (B) Representative FACS plots show the CD69/CD62L Ab staining patterns of SP thymocytes from the indicated mice, identified by single expression of either the CD4 or CD8 markers. Data are presented as described in Fig. 7. Samples from 11 additional mice of each treatment group gave similar results.
###end p 56
###begin p 57
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 344 347 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 434 453 434 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g004">Fig. 4C upper panel</xref>
###xml 542 561 542 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g004">Fig. 4C lower panel</xref>
###xml 613 616 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 711 718 711 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g005">Fig. 5C</xref>
###xml 791 794 791 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 801 807 801 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g006">Fig 6B</xref>
###xml 840 843 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 850 857 850 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g006">Fig. 6C</xref>
###xml 979 982 979 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1197 1201 <span type="species:ncbi:10090">mice</span>
A histological analysis of S1PLH/H animals at 16 weeks of age revealed relatively mild lesions that were restricted to lymphoid tissues and consistent with retention of mature lymphocytes in the thymus and secondary lymphoid organs. None of the lesions seen in S1PL-/- mice were noted in the lung, heart, bone, or urothelium of young adult S1PLH/H mice. In the thymus, the cortex contained minimally decreased numbers of lymphocytes (Fig. 4C upper panel) accompanied by a minimal expansion of the medulla by increased numbers of lymphocytes (Fig. 4C lower panel). The mesenteric and peripheral lymph nodes of S1PLH/H mice were characterized by marked expansion of paracortical areas by sequestered lymphocytes (Fig. 5C). In contrast to the severe depletion of lymphocytes in the PALS of S1PL-/- mice (Fig 6B), the splenic white pulp of S1PLH/H mice (Fig. 6C) contained essentially normal numbers and distributions of lymphocytes in the PALS and follicles. In aged (58 weeks) S1PLH/H mice, notable histopathological changes were also limited to lymphoid tissues, although there was minimal vacuolization of a few superficial urothelial cells in the urinary bladder of one of the six aged humanized mice examined (data not shown).
###end p 57
###begin p 58
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 128 131 128 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 438 441 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 557 564 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g013">Fig. 13</xref>
###xml 620 623 620 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 688 691 688 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 698 705 698 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g004">Fig. 4D</xref>
###xml 707 714 707 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g005">Fig. 5D</xref>
###xml 720 727 720 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g006">Fig. 6D</xref>
###xml 796 799 796 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 937 940 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 1057 1065 1057 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g010">Fig. 10E</xref>
###xml 1153 1161 1153 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g010">Fig. 10F</xref>
###xml 1324 1327 1324 1327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
###xml 1328 1332 <span type="species:ncbi:10090">mice</span>
To assess the phenotypic effects of even greater decreases in S1PL activity, we crossed S1PLH/H with S1PL-/- mice to obtain S1PLH/- offspring which carry a single functional copy of S1PL. S1PL activity in these S1PLH/- mice was expected to be lower than the enzyme activity in S1PLH/H mice. In fact, S1PL activity was below the level of detection levels of our enzymatic assay (data not shown). These lower levels of S1PL activity in S1PLH/- mice correlated with an additional significant reduction in circulating T lymphocytes compared to S1PLH/H animals (Fig. 13). Histopathological changes in lymphoid tissues in S1PLH/- mice were similar in type and severity to those seen in the S1PLH/H line (Fig. 4D, Fig. 5D, and Fig. 6D). Importantly, the additional reduction of S1PL activity in the S1PLH/- mice still did not elicit clinically significant lesions in any non-lymphoid tissues of young adult mice. Similarly, aged (58 weeks) S1PLH/- mice also lacked lesions in lungs or hearts, although small numbers of enlarged osteoclasts at the physis in bones (Fig. 10E), and multifocal minimal vacuolization and degeneration of urinary bladder urothelium (Fig. 10F), were present. Nevertheless, the amounts and distribution of trabecular bone in the metaphysis and diaphysis of long bones were within normal limits in aged S1PLH/- mice.
###end p 58
###begin title 59
Lymphopenia correlates proportionally with the extent of S1PL deficiency.
###end title 59
###begin p 60
###xml 165 173 165 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g012">Fig. 12A</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 94 99 <span type="species:ncbi:9606">human</span>
Blood cell counts were obtained from 75 and 30 mice carrying 2 copies or a single copy of the human knockin allele, respectively. Data are presented as described in Fig. 12A.
###end p 60
###begin title 61
Discussion
###end title 61
###begin p 62
###xml 498 501 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 813 816 813 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 822 825 822 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 835 838 835 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 1425 1429 1425 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Schwab2">[28]</xref>
###xml 1519 1523 1519 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Schwab2">[28]</xref>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
Comparative analysis of KO and humanized mice demonstrated differential effects of complete and partial inhibition of S1PL activity on general physiology versus immune function. Inactivation of S1PL resulted in increased levels of S1P in tissues and serum, and the ensuing physiological consequences correlated proportionally with the extent of S1PL deficiency. We found that clinically significant lesions in non-lymphoid tissues developed only in the complete absence of S1PL activity in the S1PL-/- mice. In contrast, the immune system was exquisitely sensitive to alterations in S1PL activity even in partial absence of S1PL. Concurrent depletion of T cells from the peripheral blood and sequestration of mature T cells within the thymic medulla and lymph nodes were observed in all three genetic models (S1PL-/-, S1PLH/H, and S1PLH/- mice). The T-cell content of secondary lymphoid organs was always less affected than would be expected from the severity of lymphopenia in the peripheral blood, even after complete loss of S1PL activity. Such altered redistribution of T lymphocytes is a hallmark of modulation of the S1P-S1P1 receptor axis and can be explained by accumulation of S1P in tissues of our S1PL-deficient genetic models. Our results are consistent with published data showing that RNA interference-mediated knockdown of S1PL in hematopoietic cells leads to increased S1P levels and a block in T-cell egress [28]. In the same study, inhibition of S1PL by the food colorant THI produced similar results [28]. Our analysis of genetic models with a wide range of systemic S1PL deficiency extend on these studies and clearly demonstrate that T-cell trafficking is particularly tightly controlled by S1PL activity compared to other physiological processes.
###end p 62
###begin p 63
###xml 351 354 351 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 710 713 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1114 1117 1114 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 1333 1336 1333 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Hait1">[2]</xref>
###xml 1338 1341 1338 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Goetzl1">[6]</xref>
###xml 1342 1345 1342 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Hung1">[8]</xref>
###xml 1347 1351 1347 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Maceyka1">[10]</xref>
###xml 1352 1356 1352 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Reiss1">[13]</xref>
###xml 1440 1444 1440 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Brinkmann1">[44]</xref>
###xml 1446 1450 1446 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Isoyama1">[45]</xref>
###xml 1595 1598 1595 1598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2338 2342 2338 2342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Takahama1">[46]</xref>
###xml 2788 2792 2788 2792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Sanna1">[25]</xref>
###xml 2794 2798 2794 2798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Mandala1">[38]</xref>
###xml 2800 2804 2800 2804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Takahama1">[46]</xref>
###xml 3046 3050 3046 3050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Kabashima1">[32]</xref>
###xml 3063 3067 3063 3067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Pappu1">[47]</xref>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
###xml 1426 1430 <span type="species:ncbi:10090">mice</span>
###xml 1435 1439 <span type="species:ncbi:10116">rats</span>
###xml 1599 1603 <span type="species:ncbi:10090">mice</span>
###xml 1901 1905 <span type="species:ncbi:10090">mice</span>
###xml 1931 1935 <span type="species:ncbi:10090">mice</span>
###xml 2168 2172 <span type="species:ncbi:10090">mice</span>
###xml 2453 2457 <span type="species:ncbi:10090">mice</span>
It appears that several mechanisms may be involved in S1PL-induced inhibition of thymocyte egress and development. It is a novel finding in our genetic models that excessive S1P levels can also disturb thymocyte development in addition to T-cell egress, leading to decreased thymic cellularity and T-cell output. This is most clearly evidenced in S1PL-/- mice by the severe hypocellularity and increased apoptosis of lymphocytes within the thymic cortex, and by the paucity of T-cells in the splenic PALS and paracortical areas of lymph nodes. It is possible that stress-related elevations in glucocorticoid levels could have contributed to lymphocyte apoptosis and hypocellularity in the thymic cortex of S1PL-/- mice; however, the lymphoid hypercellularity in the thymic medulla of these mice is not generally a feature of stress-induced thymic atrophy, suggesting that direct S1PL effects are involved. Direct S1PL effects on lymphocyte development in the thymus are also suggested by the lymphoid hypocellularity and increased apoptosis of lymphocytes we observed in the thymic cortex of clinically normal S1P H/- mice; these mice retained low level S1PL activity and the cortical lymphoid depletion was unlikely to be stress related. S1P has been shown to both promote and protect against apoptosis in different mammalian cells [2], [6]-[8], [10]-[13], and the S1P1 receptor-agonist FTY720 affects thymocyte apoptosis in mice and rats [44], [45]. In addition to its direct effect on apoptosis, excess tissue concentrations of S1P may also interfere with lympho-stromal interactions. In S1PL-/- mice, thymic epithelial cells and stromal cells that are required for T-cell selection and maturation, were highly vacuolated, which might compromise their function. The severe vacuolization of epithelial cells in the thymic cortex was largely reversed by low-level expression of S1PL in the humanized mice, but the thymus of these mice still registered a 60% reduction in thymic cellularity. Despite this apparent thymic hypocellularity, no loss of either the progenitor DN T-cell population or the mature T-cell population in the thymus was observed in the humanized mice. This suggests that loss of S1PL activity impedes the intermediary steps of T-cell maturation, which are dependent upon a complex set of lympho-stromal interactions [46]. Furthermore, we observed sequestration of lymphocytes in the thymic medulla and lymph nodes of the humanized mice but not in the spleen. These findings are consistent with some published reports that S1P-mediated retention of lymphocytes is prevalent in the thymus and lymph nodes but not in spleen, which further suggests that a tissue-specific stromal component may be involved in the S1P1 receptor-mediated control of lymphocyte trafficking [25], [38], [46]. It must be noted however that the absence of significant sequestration of lymphocytes in the spleen in our studies is in apparent conflict with other recent reports that provided evidence supporting a role for S1P in egress of both B-cells [32] and T-cells [47] from the spleen.
###end p 63
###begin p 64
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Schwab2">[28]</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Cinamon1">[30]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Kabashima1">[32]</xref>
###xml 318 321 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 752 755 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</italic>
###xml 829 833 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Suzuki1">[48]</xref>
###xml 919 922 919 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
Our finding that S1PL inhibition had a much lesser impact on B-cell homeostasis than its effects on T lymphocytes is consistent with reported differences in the ability of FTY720 or the S1PL inhibitor THI to retain T- versus B-lymphocytes [28], [30], [32]. We detected B-cell development abnormalities only in the S1PL-/- bone marrow. Similarly, increased myeloid cell numbers in the peripheral blood and infiltration of the peripheral organs was evident only in S1PL-/- mice. One explanation for the increased myeloid cell activity may be that the mobilized neutrophils and phagocytes are involved in eliminating apoptotic cells that accumulate in the infiltrated organs. Similar myeloid cell infiltration was observed in the thymus, spleen and LN of lpr mice after treatment with FTY720 which induced apoptosis in these organs [48]. Consistent with this explanation is our finding that neutrophil granulocytes of S1PL-/- mice show a significantly decreased expression of CD62L (our unpublished data), an adhesion molecule which is shed from the cell surface after cell activation, implying that granulocytes are in an activated state in these animals.
###end p 64
###begin p 65
###xml 585 588 585 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/&#8722;</sup>
###xml 597 600 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H/H</sup>
###xml 818 821 818 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1303 1307 1303 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Gon1">[49]</xref>
###xml 1373 1376 1373 1376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1761 1765 1761 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Lieschke1">[50]</xref>
###xml 1947 1951 1947 1951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Trapnell1">[51]</xref>
###xml 2076 2080 2076 2080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Buccoliero1">[52]</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 1377 1381 <span type="species:ncbi:10090">mice</span>
###xml 1587 1591 <span type="species:ncbi:10090">mice</span>
###xml 1931 1936 <span type="species:ncbi:10090">mouse</span>
###xml 1941 1946 <span type="species:ncbi:9606">human</span>
In contrast to the failed rescue of immune system phenotypes in our humanized mice, we found that even minimal S1PL activity was sufficient to prevent the development of significant lesions in non-lymphoid tissues. Among the non-lymphoid tissues, the urothelium appeared to be the most sensitive to reduced S1PL activity. Urothelial lesions could be caused by a direct effect of S1PL deficiency in urothelial cells or by excreted sphingolipid metabolites present in the urine. However, urothelial lesions were entirely absent in young adult humanized mice and were minimal in aged S1PLH/- and S1PLH/H mice. Similarly, lung pathology was not present in either of the genetic models expressing partial S1PL activity. Respiratory distress caused by pulmonary lesions was the most likely cause of reduced viability of S1PL-/- mice, as accumulations of proteinaceous exudates lining and partially filling alveoli would impair alveolar gas exchange. It is likely that the extremely elevated levels of extracellular S1P played a direct role in the development of the pulmonary lesions in the complete S1PL knockouts. One of the S1P receptors, S1P3, is expressed on alveolar epithelial cells, and airway administration of S1P has been shown to disrupt epithelial cell tight junctions and induce pulmonary edema [49]. It is likely that S1P levels are elevated in the alveoli of S1PL-/- mice and that activation of alveolar epithelial S1P3 might compromise the integrity of the pulmonary epithelial barrier. In addition, impaired function of the distended alveolar macrophages in lungs of S1PL-/- mice may also have contributed to the accumulation of proteinaceous alveolar exudates. Mutations that directly impair the development and/or function of alveolar macrophages [50], as well as mutations that inhibit degradation of surfactant within these cells, have been shown to result in alveolar proteinosis and pulmonary dysfunction in both mouse and human [51]. Surfactant dysregulation has also been proposed as a common pathogenic mechanism of several sphingolipid storage disorders [52].
###end p 65
###begin p 66
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 377 380 377 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Ryu1">[53]</xref>
###xml 518 521 518 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 794 797 794 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 890 893 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 188 193 <span type="species:ncbi:10090">mouse</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
The increased interstitial cellularity and vacuolation in the myocardium and osteopetrosis seen with the S1PL-/- mice also resolved with the minimal enzyme reconstitution in the humanized mouse lines. The myocardial lesions, while not clearly degenerative, suggest that myocardial homeostasis was altered. The molecular mechanisms responsible for the bone phenotype in the S1PL-/- mice are unclear at this point since studies have implicated S1P signaling in both osteoclast and osteoblast function [53]. However, S1PL-/- mice had an increased volume of trabecular bone in both sternebra and long bones (osteopetrosis). Bone normally undergoes a constant process of remodeling carried out by osteoclasts which resorb old bone and osteoblasts, generating new bone. The osteopetrosis seen in S1PL-/- mice appears to be the result of dysfunctional osteoclasts. The enlarged osteoclasts in S1PL-/- mice were distended by intracellular accumulations of granular eosinophilic material and were generally detached from the bone surfaces, and would therefore be physically unable to form the tight junctions and ruffled borders required for effective bone resorption.
###end p 66
###begin p 67
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 258 261 258 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 515 520 <span type="species:ncbi:10090">mouse</span>
###xml 1162 1167 <span type="species:ncbi:10090">mouse</span>
###xml 1248 1253 <span type="species:ncbi:9606">human</span>
In summary, we found that loss of S1PL activity in S1PL-/- mice results in severe T-cell depletion in the blood, thymus, spleen, and lymph nodes, as well as lesions in the lung, heart, urinary system, and bone, and that the observed reduced viability of S1PL-/- mice is most likely due to respiratory failure. Partial restoration of S1PL activity in humanized mice rescued lesions in lung, bone, and urothelium, but failed to restore normal T-cell development and trafficking. Thus, comparative analysis of genetic mouse models having differing levels of S1PL activity suggests that the S1P pathway is more stringently controlled in the immune system than in the non-lymphoid environment. The relatively specific physiological response to partial inhibition of S1PL activity suggests that there is a window within which reduced S1PL activity could produce potentially therapeutic immunosuppression without causing clinically significant S1P-related lesions in non-lymphoid target organs. Immunosuppression induced by inhibiting S1PL activity has potential application in the treatment of a variety of autoimmune and inflammatory diseases, and the humanized S1PL mouse line provides an attractive model for studying small molecule inhibitors of the human enzyme.
###end p 67
###begin title 68
Materials and Methods
###end title 68
###begin title 69
Experimental Animals
###end title 69
###begin p 70
###xml 418 428 412 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">Mice</span>
All mice analyzed were maintained on a mixed genetic background (129S5/SvEvBrd and C57BL/6J) at the ALAAC-accredited animal facility at Lexicon Pharmaceuticals Inc. Studies of gene-disrupted or humanized animals were performed using Wt littermates as controls. Mice were housed in a barrier facility at 22degreesC on a fixed 12-hour light and 12-hour dark cycle and were fed rodent chow # 5001 (Purina, St. Louis, MO) ad libitum. Procedures involving animals were conducted in conformity with the Institutional Animal Care and Use Committee guidelines that are in compliance with the state and federal laws and the standards outlined in the Guide for the Care and Use of Laboratory Animals.
###end p 70
###begin title 71
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Generation of S1PL KO mice
###end title 71
###begin p 72
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Zambrowicz1">[41]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Zambrowicz2">[54]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Zambrowicz2">[54]</xref>
###xml 351 358 351 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g001">Fig. 1A</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Zambrowicz2">[54]</xref>
###xml 591 595 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Zambrowicz2">[54]</xref>
###xml 597 604 597 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g001">Fig. 1B</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 206 211 <span type="species:ncbi:10090">mouse</span>
###xml 361 365 <span type="species:ncbi:10090">Mice</span>
Homozygous S1PL-null mice were generated by gene trapping as previously described [41], [54]. OmniBank embryonic stem cell clone OST58278 was selected for microinjection based on sequence similarity to the mouse S1PL gene (accession number NM_009163). The genomic insertion site of the gene trap vector in OST58278 was determined by inverse PCR [54] (Fig. 1A). Mice carrying this mutation were generated by using standard methods of host embryo microinjection of embryonic stem cells, chimera production, and germ-line transmission [54]. Animal genotypes were determined by quantitative PCR [54] (Fig. 1B).
###end p 72
###begin title 73
###xml 14 19 <span type="species:ncbi:9606">human</span>
Generation of human S1PL knockin allele
###end title 73
###begin p 74
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Wattler1">[55]</xref>
###xml 189 215 189 215 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTTTTGCTCAAAGCTCAGC-3&#8242;</named-content>
###xml 220 246 220 246 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTACCTGCTAAGTTCCAGG-3&#8242;</named-content>
###xml 349 387 349 387 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCCCCGGGGAGGGAGCCGGCTGCAGAGGAAG-3&#8242;</named-content>
###xml 392 428 392 428 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCAGAGCCTTCTGAGCGAGAGAGAAAGGA-3&#8242;</named-content>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URA3</italic>
###xml 921 929 921 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g011">Fig. 11A</xref>
###xml 1055 1058 1055 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 1144 1148 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-OGorman1">[56]</xref>
###xml 1220 1227 1220 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004112-g008">Fig. 8B</xref>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 455 460 <span type="species:ncbi:4932">yeast</span>
###xml 512 517 <span type="species:ncbi:4932">yeast</span>
###xml 574 579 <span type="species:ncbi:4932">yeast</span>
###xml 712 717 <span type="species:ncbi:4932">yeast</span>
###xml 756 761 <span type="species:ncbi:4932">yeast</span>
###xml 852 857 <span type="species:ncbi:9606">human</span>
###xml 1208 1213 <span type="species:ncbi:9606">human</span>
The first coding exon of the mouse S1PL gene was replaced with the human S1PL cDNA using the Lambda KOS system [55]. The Lambda KOS library was screened by PCR using the following primers: 5'-GCTTTTGCTCAAAGCTCAGC-3' and 5'-TGTACCTGCTAAGTTCCAGG-3'. A single genomic clone (pKOS-15) was isolated and confirmed by sequence analysis. Gene-specific arms 5'-AGCCCCGGGGAGGGAGCCGGCTGCAGAGGAAG-3' and 5'-CTCAGAGCCTTCTGAGCGAGAGAGAAAGGA-3' were appended by PCR to a yeast selection cassette containing the URA3 marker. The yeast selection cassette and pKOS-15 were co-transformed into yeast, and clones that had undergone homologous recombination to replace a 37 bp region containing the first coding exon of S1PL with the yeast selection cassette were isolated. The yeast cassette was subsequently replaced with a cassette containing a spliceable mini-gene, the human S1PL cDNA and the Neo selectable marker flanked by LoxP sites (Fig. 11A). The linearized targeting vector was electroporated into 129S5/SvEvBrd embryonic stem cells that contain a Protamine-driven Cre recombinase transgene to allow excision of Neo in the germline of transgenic animals [56]. RT-PCR analysis was used to demonstrate expression of the human cDNA (Fig. 8B).
###end p 74
###begin title 75
Measurement of S1PL activity
###end title 75
###begin p 76
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 408 410 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 512 513 508 509 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 769 771 761 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 1340 1342 1306 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 1517 1521 1483 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-VanVeldhoven1">[57]</xref>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
Spleens of mice were homogenized in ice-cold buffer containing 50 mM KPO4, pH 7.5, 1 mM EGTA, 1 mM DTT, and complete protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN). The homogenate was centrifuged at 2,500xg for 10 minutes, and the supernatant was used for enzyme activity measurements. Protein concentration was determined using the Bradford method. S1PL activity was determined using 33P-labeled S1P as substrate. The reactions were carried out in a 50 microl volume containing 100 mM KPO4, pH 7.4, 1 mM EDTA, 25 mM NaF, 5 mM DTT, phosphatase inhibitors I & II (Sigma-Aldrich), 0.1% Triton X-100 and various amounts of tissue lysate. The reactions were initiated by addition of pyridoxal phosphate (final concentration 50 microM) and 15 nCi of [33P]-S1P (specific activity 0.6 Ci/mmol, total S1P concentration 0.5 microM). The reaction mixtures were incubated at 37degreesC for 1 hour and terminated with the addition of 90 microl of 35% acetonitrile containing 0.1% TFA. A total of 120 microl of the mixtures were then transferred to a 96-well C18 multi-SPE plate (Millipore Corporation, Bedford, MA) pre-equilibrated first with 100 microl MeOH and then with 200 microl 20% acetonitrile containing 0.1% TFA. The plate was briefly centrifuged at 3,000 rpm for 1 minute and the filtrate was collected and assayed for 33P activity by scintillation counting. These reactions were performed in the presence and absence of 2.5 or 5 mM semicarbazide, a reactive compound that inhibits S1PL activity [57]. Activities reported represent the semicarbazide-sensitive portion of the total activity.
###end p 76
###begin title 77
Measurement of S1P concentration
###end title 77
###begin p 78
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Yatomi1">[58]</xref>
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004112-Murata1">[59]</xref>
###xml 298 300 294 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 356 357 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Extraction of S1P from mouse tissues was performed essentially as described [58] and dried under N2. S1P levels in dried extracts were quantitated using a whole cell receptor binding assay [59]. Briefly, S1P extracts or standards were resuspended in 50 microl binding buffer containing 25,000 cpm [33P]-S1P (specific activity 0.6 Ci/mmol) and added to 5x104 HEK293 cells expressing S1P1 receptor. Cells were incubated on ice for one hour then washed twice with binding buffer. Cells were lysed by addition of 100 microl lysis buffer and 40 microl of the resulting extract was added to 120 microl MS40 microscint. S1P content of extracts was estimated from standard curves (between 42 pM and 2.5 microM) generated with cold S1P standards.
###end p 78
###begin title 79
CBC and flow cytometry
###end title 79
###begin p 80
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1856 1857 1827 1828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1862 1863 1833 1834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1871 1872 1839 1840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1906 1907 1874 1875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1914 1915 1882 1883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1927 1928 1892 1893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1933 1934 1898 1899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1939 1940 1904 1905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 802 807 <span type="species:ncbi:10090">mouse</span>
###xml 901 906 <span type="species:ncbi:10090">mouse</span>
CBC analysis was performed on blood isolated from the retroorbital sinus of mice anesthetized with isofluorane using either Cell-Dyn 3500 (Abbott Diagnostics, Abbott Park, IL) or HemaVet 850 FS (Drew Scientific, Inc., Oxford, CT) instruments. For flow cytometry analysis of whole blood, erythrocytes were lysed by hypotonic shock, washed once in FACS wash buffer (FWB: PBS/0.1% BSA/0.1% NaN3/2 mM EDTA) and stained for 30 minutes at 4degreesC in the dark with the indicated combination of fluorochrome-conjugated mAbs. After staining, the cells were washed once with FWB and resuspended in 300 microl FWB for analysis. Samples were analyzed using a FACSCalibur flow cytometer and CellQuest Pro software (Becton Dickinson Immunocytometry Systems, San Jose, CA). Thymus, bone marrow (from two femurs per mouse), spleen, and lymph nodes (LN) (two inguinal, axillary, lateral axillary, and mesenteric per mouse) were harvested and dispersed into single-cell suspensions by forcing the tissue through a 70 microm cell strainer (Falcon, Becton Dickinson Labware, Bedford, MA). Single cell suspensions were analyzed by CBC and FACS as above except that prior to staining, cells were incubated with 10 microl antibody (1/10 dilution in FWB, Fc Block(R), BD BioSciences, San Jose, CA) for 15 min. at 4degreesC. The following antibodies (all from BD BioSciences, San Jose, CA) were used in this study: anti-B220-FITC, -PE, -APC and -PERCP, anti-beta7 integrin-FITC and -PE, CD4-FITC, -PE, -APC and -PERCP, CD8a- FITC, -PE, -APC and -PERCP, CD69-FITC, CD44-APC, CD24-FITC, -PE and -APC, CD62L-FITC, -PE and -APC, CD43-PE, CD45- FITC, -PE, -APC and -PERCP. The absolute number of each indicated cell subset was calculated by multiplying its fractional representation determined by FACS by the absolute number of cells identified by CBC. B cells were identified as CD19+/CD45+/TcRbeta- mononuclear cells, T cells as CD4+ or CD8+ and TcRbeta+/CD45+/CD19- mononuclear cells.
###end p 80
###begin title 81
Histopathology
###end title 81
###begin p 82
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Tissues collected from genetically modified mice and age-matched Wt control mice were immersion fixed in 10% neutral buffered formalin, except eyes, which were fixed for 24 h in Davidson's fixative. All tissues were embedded in paraffin, sectioned at 4 microm, and mounted on positively charged glass slides (Superfrost Plus, Fisher Scientific, Pittsburgh, PA) and stained with hematoxylin and eosin for histopathologic examination.
###end p 82
###begin title 83
Statistics
###end title 83
###begin p 84
Analysis of statistical significance of group differences was performed using the two-sample t-test. In all tests, a P value of <0.05 was considered significant.
###end p 84
###begin p 85
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
We thank the phenotypic analysis groups at Lexicon Pharmaceuticals Inc. for carrying out the comprehensive clinical diagnostic tests on the S1PL mutant mouse lines, and C.A. Turner, J. Shaw, and W. Walke for critical reading of the manuscript. We also thank Dongxia Xing, Mary Thiel, Kathy Henze, Lindsey Guthrie for technical support. The authors of this article are or have been employees of, and received stock options from, Lexicon Pharmaceuticals Inc.
###end p 85
###begin title 86
References
###end title 86
###begin article-title 87
Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling.
###end article-title 87
###begin article-title 88
Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.
###end article-title 88
###begin article-title 89
Cellular signalling by sphingosine kinase and sphingosine 1-phosphate.
###end article-title 89
###begin article-title 90
Sphingosine 1-phosphate signalling in mammalian cells.
###end article-title 90
###begin article-title 91
###xml 17 41 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase.
###end article-title 91
###begin article-title 92
Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
###end article-title 92
###begin article-title 93
Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells.
###end article-title 93
###begin article-title 94
###xml 53 58 <span type="species:ncbi:9606">human</span>
Induction of apoptosis by sphingosine-1-phosphate in human hepatoma cells is associated with enhanced expression of bax gene product.
###end article-title 94
###begin article-title 95
Distinctive T cell-suppressive signals from nuclearized type 1 sphingosine 1-phosphate G protein-coupled receptors.
###end article-title 95
###begin article-title 96
SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism.
###end article-title 96
###begin article-title 97
Sphingosine-1-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes.
###end article-title 97
###begin article-title 98
Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer.
###end article-title 98
###begin article-title 99
Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis.
###end article-title 99
###begin article-title 100
Point-counterpoint of sphingosine 1-phosphate metabolism.
###end article-title 100
###begin article-title 101
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.
###end article-title 101
###begin article-title 102
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.
###end article-title 102
###begin article-title 103
Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol.
###end article-title 103
###begin article-title 104
Sphingosine-phosphate lyase.
###end article-title 104
###begin article-title 105
Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes.
###end article-title 105
###begin article-title 106
Storage diseases: new insights into sphingolipid functions.
###end article-title 106
###begin article-title 107
PDGF signaling specificity is mediated through multiple immediate early genes.
###end article-title 107
###begin article-title 108
Cutting edge: Alternative signaling of Th17 cell development by sphingosine 1-phosphate.
###end article-title 108
###begin article-title 109
Sphingolipids in inflammation: roles and implications.
###end article-title 109
###begin article-title 110
In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights.
###end article-title 110
###begin article-title 111
Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.
###end article-title 111
###begin article-title 112
Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.
###end article-title 112
###begin article-title 113
Finding a way out: lymphocyte egress from lymphoid organs.
###end article-title 113
###begin article-title 114
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
###end article-title 114
###begin article-title 115
CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
###end article-title 115
###begin article-title 116
Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone.
###end article-title 116
###begin article-title 117
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes.
###end article-title 117
###begin article-title 118
Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism.
###end article-title 118
###begin article-title 119
Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit.
###end article-title 119
###begin article-title 120
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
###end article-title 120
###begin article-title 121
S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress.
###end article-title 121
###begin article-title 122
Emerging medicinal roles for lysophospholipid signaling.
###end article-title 122
###begin article-title 123
New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
###end article-title 123
###begin article-title 124
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
###end article-title 124
###begin article-title 125
Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist.
###end article-title 125
###begin article-title 126
FTY720: a most promising immunosuppressant modulating immune cell functions.
###end article-title 126
###begin article-title 127
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells.
###end article-title 127
###begin article-title 128
Immunosuppressant FTY720 inhibits thymocyte emigration.
###end article-title 128
###begin article-title 129
Recent thymic emigrants are distinct from most medullary thymocytes.
###end article-title 129
###begin article-title 130
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects.
###end article-title 130
###begin article-title 131
###xml 29 32 <span type="species:ncbi:10116">rat</span>
Evidence that FTY720 induces rat thymocyte apoptosis.
###end article-title 131
###begin article-title 132
Journey through the thymus: stromal guides for T-cell development and selection.
###end article-title 132
###begin article-title 133
Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.
###end article-title 133
###begin article-title 134
###xml 61 65 <span type="species:ncbi:10090">mice</span>
The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720.
###end article-title 134
###begin article-title 135
S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF.
###end article-title 135
###begin article-title 136
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease.
###end article-title 136
###begin article-title 137
Pulmonary alveolar proteinosis.
###end article-title 137
###begin article-title 138
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Increased lung surfactant phosphatidylcholine in patients affected by lysosomal storage diseases.
###end article-title 138
###begin article-title 139
Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling.
###end article-title 139
###begin article-title 140
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.
###end article-title 140
###begin article-title 141
Construction of gene targeting vectors from lambda KOS genomic libraries.
###end article-title 141
###begin article-title 142
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells.
###end article-title 142
###begin article-title 143
###xml 83 86 <span type="species:ncbi:10116">rat</span>
Subcellular localization and membrane topology of sphingosine-1-phosphate lyase in rat liver.
###end article-title 143
###begin article-title 144
Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride.
###end article-title 144
###begin article-title 145
Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay.
###end article-title 145
###begin p 146
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
###xml 169 174 <span type="species:ncbi:10090">mouse</span>
Competing Interests: All authors are paid employees of Lexicon Pharmaceuticals and all hold stock options in the company. A patent application on the S1P Lyase knockout mouse lines described in the paper is pending but has not been issued.
###end p 146
###begin p 147
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The work described in this paper was funded by Lexicon Pharmaceuticals, Inc. All authors are employees of Lexicon Pharmaceuticals, Inc and in this respect the company had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 147

